Figure 4 | British Journal of Cancer

Figure 4

From: Health-related quality of life impact of cobimetinib in combination with vemurafenib in patients with advanced or metastatic BRAFV600 mutation–positive melanoma

Figure 4

Proportion of patients with clinically meaningful improvement in EORTC QLQ-C30 scores at ⩾1 post-baseline time point. Clinically meaningful improvement is defined as a ⩾10-point increase in scores for global health status and functioning scales or a ⩾10-point decrease in scores for symptom scales. EORTC QLQ-C30=European Organisation for Research and Cancer Quality of Life Questionnaire Core 30.

Back to article page